ARM three-lens brief
Evidence-based stock research on ARM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · P/E of 381 — priced for high growth; little margin of safety.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- P/E of 381 — priced for high growth; little margin of safety.
- Earnings scheduled 2026-07-29.
ARM closed at $324.04 (-1.17%) as of 2026-07-10. Market cap: $346.09B. P/E (trailing) 381.2. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.. Concerns: p/E of 381 — priced for high growth; little margin of safety.. Last quarter: Revenue $1.49B, net income $313.00M, free cash flow $750.50M. Watching for: 2026-07-29 earnings release (18 days out).
Why three lenses on ARM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ARMacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ARM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ARM brief"></iframe>